Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine PK and Food Effect Study
NCT02165098Phase 1Completed
- Sponsor
- Gedeon Richter Plc
- Start
- Jun 2014
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cariprazine in schizophrenia and bipolar disorder (BD) (5 arms), sponsored by Gedeon Richter Plc. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve and 1 more. Started Jun 2014; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophreniabipolar disorder (BD)
Beyond the preview
Go deeper on NCT02165098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02165098.